LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 19.69 | 84.90 | 21 | 1239 | 0.0169 | -0.3031 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 19.69 | 84.90 | 1181 | 1239 | 0.9529 | 0.9752 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 19.69 | 84.90 | 54 | 1239 | 0.0436 | -0.1104 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 19.69 | 84.90 | 1681 | 1239 | 1.3563 | 1.1640 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 21.40 | 84.90 | 16 | 1454 | 0.0110 | -0.3345 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 21.40 | 84.90 | 1280 | 1454 | 0.8799 | 0.9386 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 21.40 | 84.90 | 87 | 1454 | 0.0598 | 0.0060 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 21.40 | 84.90 | 1861 | 1454 | 1.2793 | 1.1239 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 23.10 | 84.90 | 33 | 1616 | 0.0204 | -0.1993 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 23.10 | 84.90 | 1357 | 1616 | 0.8396 | 0.9194 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 23.10 | 84.90 | 110 | 1616 | 0.0681 | 0.0628 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 23.10 | 84.90 | 2018 | 1616 | 1.2486 | 1.1072 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 24.81 | 84.90 | 35 | 1769 | 0.0198 | -0.1831 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 24.81 | 84.90 | 1488 | 1769 | 0.8409 | 0.9225 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 24.81 | 84.90 | 116 | 1769 | 0.0656 | 0.0738 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 24.81 | 84.90 | 2138 | 1769 | 1.2083 | 1.0882 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 26.51 | 84.90 | 50 | 1923 | 0.0260 | -0.1110 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 26.51 | 84.90 | 1614 | 1923 | 0.8392 | 0.9236 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 26.51 | 84.90 | 148 | 1923 | 0.0770 | 0.1314 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 26.51 | 84.90 | 2312 | 1923 | 1.2022 | 1.0835 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 28.21 | 84.90 | 80 | 2091 | 0.0383 | -0.0128 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 28.21 | 84.90 | 1761 | 2091 | 0.8420 | 0.9270 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 28.21 | 84.90 | 164 | 2091 | 0.0784 | 0.1531 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 28.21 | 84.90 | 2469 | 2091 | 1.1805 | 1.0731 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 29.92 | 84.90 | 89 | 2237 | 0.0398 | 0.0101 | MN20160318_Q02 | D17 |